Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
A great proportion of acute myeloid leukemias (AMLs) display cytogenetic abnormalities including chromosomal aberrations and/or submicroscopic mutations. These abnormalities significantly influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback